C
Overview
CSI Pharmacy is a nationwide specialty infusion pharmacy that provides home infusion immunoglobulin (Ig) therapy for people with rare and chronic conditions. Infusions are given at patients’ homes by trained nurses and pharmacists, with insurance support to simplify access and billing. The company distinguishes itself through dedicated clinical and advocacy teams that coordinate care and offer comprehensive services, including pharmacy and insurance assistance, on a nationwide scale. Its goal is to improve health outcomes and quality of life by delivering seamless, coordinated infusion treatment and support in the home setting.
Work here?Claim your company
Simplify's take
What believers are saying
- April 2026 accreditation strengthens referral confidence from immunologists and rare-disease clinicians.
- Aetna’s PANS/PANDAS policy listing broadens reimbursable demand for CSI’s patient base.
- 2026 workplace awards support hiring in a labor-tight specialty pharmacy market.
What critics are saying
- Single-product concentration in Ig therapy exposes CSI to payer pressure and reimbursement cuts.
- Any sterilization, diversion, or dispensing lapse invites state-board sanctions and patient-flight within months.
- National specialty rivals and health-system pharmacies can undercut CSI’s home-infusion access advantage.
What makes CSI Pharmacy unique
- April 2026 ACHC-IgNS distinction makes CSI first multi-location Ig specialist with that credential.
- Licensed in all 50 states, CSI can route immunoglobulin therapy nationwide.
- Tampa 2025 and Plano 2026 expansions strengthened local fulfillment and patient access.
Help us improve and share your feedback! Did you find this helpful?